4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-22-007990
Chairman and CEO bought 8,500 shares at an average $1.48 ($12,560)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2022-02-07 | Purchase | +5,250 | $1.47 | $7,718 | 11,160,656 | D |
| Niihara Yutaka Chairman and CEO | 2022-02-08 | Purchase | +3,250 | $1.49 | $4,843 | 11,163,906 | D |
| Open-market purchases · 8,500 sh · avg $1.48 · $12,560 | |||||||
Loading xslF345X03/doc4.xml…